Kroll Werner has filed 16 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 1170 shares of QuidelOrtho Corp ($QDEL) on July 28, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Common Stock | 1170 | $0.00 | 36,951.0000 | 66,800,000 | 3.27% | 0.00% |
| July 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | F | Common Stock | 594 | $38.91 | 36,357.0000 | 66,800,000 | 1.61% | 0.00% |
| July 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | M | Restricted Stock Units | 1170 | $0.00 | 0.0000 | 66,800,000 | 100.00% | 0.00% |
| March 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Common Stock | 3811 | $0.00 | 37,582.0000 | 66,800,000 | 11.28% | 0.01% |
| March 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | F | Common Stock | 1801 | $47.94 | 35,781.0000 | 66,800,000 | 4.79% | 0.00% |
| March 28, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | M | Restricted Stock Units | 3811 | $0.00 | 7,622.0000 | 66,800,000 | 33.33% | 0.01% |
| Feb. 8, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Restricted Stock Units | 14920 | $0.00 | 14,920.0000 | 66,800,000 | 9999.99% | 0.02% |
| Feb. 1, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Common Stock | 1313 | $0.00 | 34,451.0000 | 66,800,000 | 3.96% | 0.00% |
| Feb. 1, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | F | Common Stock | 680 | $69.45 | 33,771.0000 | 66,800,000 | 1.97% | 0.00% |
| Feb. 1, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | M | Restricted Stock Units | 1313 | $0.00 | 0.0000 | 66,800,000 | 100.00% | 0.00% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Common Stock | 3628 | $0.00 | 33,343.0000 | 66,800,000 | 12.21% | 0.01% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | F | Common Stock | 1946 | $68.51 | 31,397.0000 | 66,800,000 | 5.84% | 0.00% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | A | Common Stock | 3547 | $0.00 | 34,944.0000 | 66,800,000 | 11.30% | 0.01% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | F | Common Stock | 1806 | $68.51 | 33,138.0000 | 66,800,000 | 5.17% | 0.00% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | M | Restricted Stock Units | 3628 | $0.00 | 3,628.0000 | 66,800,000 | 50.00% | 0.01% |
| Jan. 31, 2024 | QuidelOrtho Corp | $QDEL | Kroll Werner | SVP, Research & Development | M | Restricted Stock Units | 3547 | $0.00 | 3,548.0000 | 66,800,000 | 49.99% | 0.01% |